Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT00016224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cance
ClinicalTrials.gov study NCT06199895. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT03709550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI
ClinicalTrials.gov study NCT02066870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
ClinicalTrials.gov study NCT07226713. IPD Sharing: NO. Countries: 1. Publications: 0.
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
ClinicalTrials.gov study NCT04381832. IPD Sharing: YES. Countries: 2. Publications: 0.
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
ClinicalTrials.gov study NCT02640534. IPD Sharing: NO. Countries: 1. Publications: 0.
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)
ClinicalTrials.gov study NCT06978296. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02113657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT02135757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT04918810. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)
ClinicalTrials.gov study NCT03076203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT07090369. IPD Sharing: NO. Countries: 1. Publications: 0.
Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies
ClinicalTrials.gov study NCT06024538. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT05533203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
ClinicalTrials.gov study NCT04868045. IPD Sharing: YES. Countries: 0. Publications: 0.
Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy
ClinicalTrials.gov study NCT05295589. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03639246. IPD Sharing: NO. Countries: 1. Publications: 0.
ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib
ClinicalTrials.gov study NCT03097601. IPD Sharing: NO. Countries: 1. Publications: 0.
Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
ClinicalTrials.gov study NCT02588001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.